6 Related NICE guidance
Published
-
Cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen (2012) NICE technology appraisal guidance 255
-
Prostate cancer: diagnosis and treatment (2008) NICE guideline CG58
-
Docetaxel for the treatment of hormone refractory prostate cancer (2006) NICE technology appraisal guidance 101
-
Improving outcomes in urological cancers (2002) NICE guideline CSG2